Search - tctmd.com

Displaying 141 - 160 of 198

Sort: Relevancy | Date

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

TATORT-NSTEMI: Still No Role for Thrombus Aspiration in NSTEMI

Shelley Wood

November 19, 2015

News Conference News TCT 2015

Manual Thrombectomy Does Not Improve Outcomes in High-Risk STEMI Patients

October 14, 2015

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Industry News

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

September 09, 2015

News Conference News ESC 2015

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

Caitlin E. Cox

August 31, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Industry News

A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market

May 28, 2015

News Conference News EuroPCR 2015

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

Caitlin E. Cox

May 22, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Daily News

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Yael L. Maxwell

February 25, 2015

News Daily News

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

January 28, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

News Daily News

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

December 04, 2014

News Daily News

Disease Outside of Culprit Artery Tied to Greater Short-term Mortality After STEMI

Todd Neale

November 20, 2014

Advertisement

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

TATORT-NSTEMI: Still No Role for Thrombus Aspiration in NSTEMI

Manual Thrombectomy Does Not Improve Outcomes in High-Risk STEMI Patients

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

DES, BMS Both Suitable for Treating Patients With SVG Lesions

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

Silent A-fib After Acute MI Portends Poor Outcome

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Substudy Suggests Invasive Strategy Better for Elderly NSTE-ACS Patients

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

Disease Outside of Culprit Artery Tied to Greater Short-term Mortality After STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content